Alert icon
We're changing our privacy policy. This stuff matters.  Learn more  Dismiss

CorporateProfile.com features Cleveland Biolabs (CBLI) and their radiation mitigator drug CBLB502

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
227 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Feb 8, 2010

Annamaria from CorporateProfile.com talks about Cleveland Biolabs (CBLI), the recent New York Times article on the negative side effects of chemotherapy, and CBLB502, a new drug that mitigates the adverse effects of radiation

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (0)

Sign In or Sign Up now to post a comment!
Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more